Home › NCT06846047

Therapeutic Effects of Electrical Vestibular Stimulation (EVS) on Balance and Gait

Who can join

Ages 18 to 100 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

1. Able to complete balance assessments such as standing with feet together/eyes open and feet together/eyes closed, both for at least 1 minute at a time, with no more than 1 minute rest required between tests.
2. Able to complete gait assessment tests such as walking up to 200m on a flat surface without assistance.

Exclusion Criteria:

1. Participants must not be using a pacemaker, cochlear implant, or any other implanted electronic device.
2. Participants must be free from any diagnosed neurological or musculoskeletal injuries and/or disorders other than those explicitly being investigated (i.e., vertigo, multiple sclerosis, Parkinson's disease, concussion).
3. Participants must have the mental capacity to provide consent and perform tasks required by the experiment.

About the study

The aim of the study to is determine the safety, feasibility, efficacy, and persistence of non-invasive EVS to improve balance and gait performance in healthy individuals across the lifespan. Specifically, our objective is to measure balance and gait performance before, during and after exposure to single sessions and across repeated sequences of EVS at multiple study partner sites.

What is being tested

• electrical vestibular stimulation (EVS) (device)
• Sham Comparator (device)

Sponsor: Neursantys Inc · Participants: 500 · Started: Jan 20, 2025

Contact the study team

• Ryan M Peters, PhD · Phone: 403-606-5506
• John D Ralston, PhD · Phone: 650-2158-418

Official record on ClinicalTrials.gov — NCT06846047

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.